Klebsiella can normally be present in human stool. A high GI-MAP result means the targeted group’s DNA exceeds the laboratory’s reference range; it does not by itself diagnose pneumonia, a urinary infection or an antibiotic-resistant infection. The specimen and the clinical situation matter.
On this page
Why a stool finding differs from an infection
CDC describes Klebsiella in normal stool as well as its ability to cause infections such as pneumonia or bloodstream infection. A result from one specimen type cannot establish disease at a different body site. Some strains are resistant to antibiotics, but a genus name alone does not identify those strains. [1]
What the GI-MAP group result means
GI-MAP includes a Klebsiella group target and a separate K. pneumoniae line. A high group result measures targeted DNA above the laboratory’s range; it does not identify every species or establish toxin production. [2]
What it cannot tell you about autoimmune disease
The report’s association-based category does not diagnose an autoimmune condition or show that Klebsiella caused joint pain. Research associations are not equivalent to an individual causal finding. Do not use the count to replace a rheumatologic or gastrointestinal assessment.
Likewise, a normal or low stool result cannot exclude a urinary or respiratory infection. Those concerns need appropriate examination and specimens.
Useful questions for follow-up
Ask whether the genus or the species result is relevant to your symptoms, whether confirmation is necessary, and what outcome an intervention is intended to improve. A lower stool number alone is not proof of successful treatment of another condition.
How to read the group and species lines together
The genus result answers a broader question than the separate Klebsiella pneumoniae result. A high group line does not identify every species or strain contributing to it. A normal K. pneumoniae line does not make a high group result impossible: the two targets are not interchangeable.
Do not add the two values to calculate a “total Klebsiella load.” The species belongs within the broader group, and assay targets or reporting rules may overlap. If the relationship between the numbers affects a clinical decision, ask the laboratory to explain what each target includes.
What would make the finding clinically relevant?
CDC distinguishes normal stool carriage from infections assessed with a specimen sent to a laboratory. People receiving hospital care, those with invasive devices and some people exposed to prolonged antibiotics have greater infection risk. These are clinical risk factors, not a prediction that a particular stool flag will become an infection. [1]
- Digestive symptoms: discuss the symptom pattern and other plausible explanations. A genus count does not prove that Klebsiella caused bloating or diarrhea.
- Symptoms elsewhere: urinary, respiratory or wound symptoms need assessment of that site. A normal stool result cannot exclude disease there.
- A resistance concern: ask which organism and resistance mechanism were actually tested. A high bacterial quantity does not tell you which antibiotic would work.
For example, a high stool group result in a person who feels well is not the same finding as a positive culture from an infected wound. Both may involve the same genus, but they answer different questions and can lead to different care decisions.
Common questions
Does Klebsiella in stool mean pneumonia?
No. Pneumonia is a clinical condition requiring assessment of the lungs; the genus may be present in stool without that illness.
Can the result tell if I have carbapenem-resistant Klebsiella?
Not from the group quantity alone. Relevant resistance or susceptibility testing is required.
Does high Klebsiella mean I need antibiotics?
Not on the stool flag alone. The clinician needs to decide whether there is an infection or another condition requiring treatment. The group quantity cannot select an antibiotic.
Is a Klebsiella stool result a test for SIBO?
No. It does not locate bacteria in the small intestine. If symptoms warrant a SIBO assessment, discuss the appropriate pathway rather than treating a stool genus result as confirmation.
Sources and review
Sources checked November 1, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- CDC: About Klebsiella
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
This article, including the November 1 update, has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.